Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

New Nitric Oxide Donor NCX 1443: Therapeutic Effects on Pulmonary Hypertension in the SAD Mouse Model of Sickle Cell Disease.

Abid S, Kebe K, Houssaïni A, Tomberli F, Marcos E, Bizard E, Breau M, Parpaleix A, Tissot CM, Maitre B, Lipskaia L, Derumeaux G, Bastia E, Mekontso-Dessap A, Adnot S.

J Cardiovasc Pharmacol. 2018 May;71(5):283-292. doi: 10.1097/FJC.0000000000000570.

PMID:
29438213
2.

mTOR pathway activation drives lung cell senescence and emphysema.

Houssaini A, Breau M, Kebe K, Abid S, Marcos E, Lipskaia L, Rideau D, Parpaleix A, Huang J, Amsellem V, Vienney N, Validire P, Maitre B, Attwe A, Lukas C, Vindrieux D, Boczkowski J, Derumeaux G, Pende M, Bernard D, Meiners S, Adnot S.

JCI Insight. 2018 Feb 8;3(3). pii: 93203. doi: 10.1172/jci.insight.93203. eCollection 2018 Feb 8.

3.

Selective Tuberous Sclerosis Complex 1 Gene Deletion in Smooth Muscle Activates Mammalian Target of Rapamycin Signaling and Induces Pulmonary Hypertension.

Houssaini A, Abid S, Derumeaux G, Wan F, Parpaleix A, Rideau D, Marcos E, Kebe K, Czibik G, Sawaki D, Treins C, Dubois-Randé JL, Li Z, Amsellem V, Lipskaia L, Pende M, Adnot S.

Am J Respir Cell Mol Biol. 2016 Sep;55(3):352-67. doi: 10.1165/rcmb.2015-0339OC.

PMID:
26991739
4.

Telomere Dysfunction and Cell Senescence in Chronic Lung Diseases: Therapeutic Potential.

Adnot S, Amsellem V, Boyer L, Marcos E, Saker M, Houssaini A, Kebe K, Dagouassat M, Lipskaia L, Boczkowski J.

Pharmacol Ther. 2015 Sep;153:125-34. doi: 10.1016/j.pharmthera.2015.06.007. Epub 2015 Jun 18. Review.

PMID:
26096607
5.

Association of inconclusive sera for human immunodeficiency virus infection with malaria and Epstein-Barr virus infection in Central Africa.

Mbopi-Keou FX, Ndjoyi-Mbiguino A, Talla F, Péré H, Kebe K, Matta M, Sosso MA, Bélec L.

J Clin Microbiol. 2014 Feb;52(2):660-2. doi: 10.1128/JCM.02945-13. Epub 2013 Dec 4.

6.

The case for addressing primary resistance mutations to non-nucleoside reverse transcriptase inhibitors to treat children born from mothers living with HIV in sub-Saharan Africa.

Kébé K, Bélec L, Diop Ndiaye H, Bousso Gueye S, Abdallah Malick Diouara A, Ngom S, Rama Diagne Gueye N, Mbaye N, Signaté Sy H, Mboup S, Touré Kane C.

J Int AIDS Soc. 2014 Jan 16;17:18526. doi: 10.7448/IAS.17.1.18526. eCollection 2014.

7.

Performance of the ViroSeq HIV-1 genotyping system v2.0 on HIV-1 strains circulating in Senegal.

Thiam M, Diop-Ndiaye H, Kebe K, Vidal N, Diakhate-Lô R, Diouara AA, Leye N, Ndiaye O, Sow A, Ngom-Gueye NF, Mboup S, Toure-Kane C.

J Virol Methods. 2013 Mar;188(1-2):97-103. doi: 10.1016/j.jviromet.2012.11.044. Epub 2012 Dec 21.

PMID:
23266258
8.

High rate of antiretroviral drug resistance mutations in HIV type 1-infected Senegalese children in virological failure on first-line treatment according to the World Health Organization guidelines.

Kebe K, Thiam M, Diagne Gueye NR, Diop H, Dia A, Signate Sy H, Charpentier C, Belec L, Mboup S, Toure Kane C.

AIDS Res Hum Retroviruses. 2013 Feb;29(2):242-9. doi: 10.1089/aid.2011.0300. Epub 2012 Aug 3.

PMID:
22860571
9.

RNA versus DNA (NucliSENS EasyQ HIV-1 v1.2 versus Amplicor HIV-1 DNA test v1.5) for early diagnosis of HIV-1 infection in infants in Senegal.

Kébé K, Ndiaye O, Ndiaye HD, Mengue PM, Guindo PM, Diallo S, Léye N, Gueye SB, Diallo AG, Kane CT, Mboup S.

J Clin Microbiol. 2011 Jul;49(7):2590-3. doi: 10.1128/JCM.02402-10. Epub 2011 May 4.

Supplemental Content

Support Center